← Leaderboards
Michael J Oldham
Yaso Therapeutics Inc
$644,063
Attributed
$2,119,663
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $985.3K · FY2006–18$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$2,119,663 · 2
By mechanism
R44$1,967,467 · 1
R41$152,196 · 1
Top collaborators
- Barbara Best North2 shared
- Donald P Waller2 shared
- Mary B Weitzel2 shared
Most similar at Yaso Therapeutics Inc
Same institution · by research overlap
- Mary B Weitzel$1,959,557
- Barbara Best North$1,565,832
- Aleksej Krunic$95,204
- Beatrice A. Chen$77,995
Others in their field
Top investigators on “Acrosin”
- Jerome Frank Strauss · University Of Pennsylvania$2,555,166
- Robert Vessella · University Of Washington$2,296,833
- Angelique Wright Whitehurst · Ut Southwestern Medical Center$1,501,419
- William Sonnenburg · Baylor College Of Medicine$952,767
- Stefan Schlatt · University Of Pittsburgh At Pittsburgh$787,621
- Joseph V. Califano · Virginia Commonwealth University$554,625
Research focus
AcrosinAcrosomeAdverse EffectsAnalytical MethodAnimalsApplications GrantsBaseBindingBiological MarkersBirth ControlCervicalCharacteristicsChemistryClinical ProtocolsClinical ResearchClinical Trial Protocol DocumentClinical TrialsCoitusComplementComplexContraceptive AgentsContraceptive EfficacyContraceptive PracticeAbsorption